PeptiSystems offers a new generation of instruments for solid-phase synthesis production of peptide and oligonucleotide therapeutics. Our instruments are used for process development and large-scale GMP and non-GMP manufacturing based on flowthrough column technology.
Total raised: $4.05M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 20.12.2024 | - | $4.05M | - |
Mentions in press and media 2
| Date | Title | Description |
| 20.12.2024 | Sciety and Sciety Venture Partners invest EUR 3.9 million in PeptiSystems | Sciety and Sciety Venture Partners invest EUR 3.9 million in PeptiSystems Fri, Dec 20, 2024 07:00 CET Report this content Sciety and Sciety Venture Partners have invested EUR 3.9 million in PeptiSystems, a biotech company developing advance... |
| - | PeptiSystems | “PeptiSystems offers a new generation of instruments for solid-phase synthesis production of peptide and oligonucleotide therapeutics. Our instruments are used for process development and large-scale GMP and non-GMP manufacturing based on f... |